Press Releases

Date	Title	PDF Version
Feb 27, 2015	Alexion Joins Patient Organizations Worldwide in Support of International Rare Disease Day 2015
Feb 23, 2015	Alexion to Present at Investor Conferences
Feb 09, 2015	New Data from a Natural History Study in Patients with Infantile- and Juvenile-Onset Hypophosphatasia Accepted as Late-Breaking Abstracts at the ENDO 2015 Annual Meeting
Feb 05, 2015	Alexion to Present at the 2015 Leerink Global Healthcare Conference
Jan 29, 2015	Alexion Appoints David L. Hallal as Chief Executive Officer, Effective April 1, 2015
Jan 29, 2015	Alexion Reports Fourth Quarter and Full Year 2014 Results and Provides Financial Guidance for 2015
Jan 21, 2015	Alexion Pharmaceuticals to Report Fourth Quarter and Full Year 2014 Results on Thursday, January 29, 2015
Jan 20, 2015	Researchers to Present New Data on Asfotase Alfa in Children with Hypophosphatasia (HPP) as well as Burden of Disease Data in Adults with HPP at ENDO 2015 Annual Meeting
Jan 07, 2015	Alexion Provides Update on Phase 2 Clinical Trial with Eculizumab in Antibody Mediated Rejection (AMR) in Living-Donor Kidney Transplant Recipients
Jan 05, 2015	Alexion to Present at the J.P. Morgan 33rd Annual Healthcare Conference

Search